Stability Challenges in High-Concentration Biologic Formulations
Stability Challenges in High-Concentration Biologic Formulations Managing Stability Concerns in High-Concentration Biologic Formulations As the demand for self-administered biologics increases, pharmaceutical companies are developing high-concentration formulations (HCFs) to enable subcutaneous delivery of large therapeutic doses in small injection volumes. While these formulations offer patient-centric benefits, they introduce significant challenges related to physical and chemical stability….
Read More “Stability Challenges in High-Concentration Biologic Formulations” »